Pharmacokinetics and bioequivalence study of two mosapride citrate formulations after single-dose administration in healthy Chinese male volunteers

Arzneimittel-Forschung/Drug Research

Volumn 61, Issue 3, 2011, Pages 167-172

  Huang, Jun ^a   Tian, Yuan ^a   Zhang, Zun Jian ^a   Li, Jinheng ^b   Cao, Xiaomei ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

Bioequivalence; CAS 112885 42 4; Gastroprokinetic agent; Mosapride citrate; Pharmacokinetics

Indexed keywords

MOSAPRIDE CITRATE;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG FORMULATION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 79953242121     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296184     Document Type: Article

References (8)

1. Curran MP, Robinson DM. Mosapride in gastrointestinal disorders. Drugs. 2008;68(7):981-91.
2. Yoshida N. Pharmacological effects of the gastroprokinetic agent mosapride citrate. Folia Pharmacol. 1999;113:299-307. (Pubitemid 29254500)
3. 4 receptor agonist. J Surg Res. 2010;159(2):696-704.
4. Sakashita M, Mizuki Y, Hashizume T, Yamaguchi T, Miyazaki H, Sekine Y. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats. Arzneimittelforschung. 1993;43(8):859-63. (Pubitemid 23254934)
5. Sakashita M, Mizuki Y, Yamaguchi T, Miyazaki H, Sekine Y. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys. Arzneimittelforschung. 1993;43(8):864-6. (Pubitemid 23254935)
6. Sakashita M, Yamaguchi T, Miyazaki H, Sekine Y, Nomiyama T, Tanaka S, et al. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. Arzneimittelforschung. 1993;43(8):867-72. (Pubitemid 23254936)
7. Katoh T, Saitoh H, Ohno N, Tateno M, Nakamura T, Dendo I, et al. Drug interaction between mosapride and erythromycin without electrocardiographic changes. Jpn Heart J. 2003;44(2):225-34. (Pubitemid 41519021)
8. US Department of Health and Human Services. Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Guidance for Industry, Bioanalytical Method Validation. 2001.